News Home

What is the Market's View on Fate Therapeutics Inc (FATE) Stock's Price and Volume Trends Thursday?

Thursday, November 18, 2021 10:24 AM | InvestorsObserver Analysts
What is the Market's View on Fate Therapeutics Inc (FATE) Stock's Price and Volume Trends Thursday?

The market has been down on Fate Therapeutics Inc (FATE) stock recently. FATE gets a Bearish score from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,bearish
Fate Therapeutics Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on FATE!

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With FATE Stock Today?

Fate Therapeutics Inc (FATE) stock has risen 0.37% while the S&P 500 has fallen 0% as of 10:23 AM on Thursday, Nov 18. FATE has risen $0.20 from the previous closing price of $53.48 on volume of 85,389 shares. Over the past year the S&P 500 has gained 29.90% while FATE has risen 2.40%. FATE lost -$2.13 per share in the over the last 12 months. To see InvestorsObserver's Sentiment Score for Fate Therapeutics Inc click here.

More About Fate Therapeutics Inc

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and immune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients. Click Here to get the full Stock Report for Fate Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App